British Society for Immunology Congress 2017 | 4 - 7 December, Brighton UK

Jordi Ochando

Icahn School of Medicine at Mount Sinai, USA

 

Dr. Jordi Ochando obtained his PhD from the De Montfort University in Leicester and was a post-doctoral fellow at Mount Sinai School of Medicine in New York.

His laboratory investigates the origin, development, and immune regulatory functions of monocyte-derived macrophages. As negative regulators of the immune response, monocyte-derived macrophages represent a novel therapeutic approach to manipulate the immune response through lectin and toll like receptors. His laboratory has recently developed a novel revolutionary targeted therapeutic delivery approach in which drug-loaded nanoparticles that specifically target myeloid cells in vivo induce long-term allograft acceptance with minimal immunosuppressive drug usage.